Hosted on MSN20d
Rhythm gets FDA approval for Imcivree for toddlersImcivree, also known as setmelanotide, initially received approval from the FDA in November 2020 for patients six years old and older with POMC, PCSK1 or LEPR deficiencies. It was approved in June ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback